# Niva Bupa Health Insurance Company share price today (Niva Bupa Health Insurance Company Ltd, NSE: NIVABUPA)

> Niva Bupa Health Insurance Company share price today: ₹73.35 at the NSE close on 3 November 2026, down 2.3% in a year. Niva Bupa Health Insurance Company (NSE: NIVABUPA) is worth ₹13,574 crore, trades at a P/BV of 3.6 and has closed between ₹69.93 and ₹87.01 over the past 52 weeks. > Niva Bupa Health Insurance Company Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. NIVABUPA · Finance - Insurance · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/niva-bupa-health-insurance-company-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: ₹73.35 (−2.3% in a year)
- P/BV: 3.6× (lower than 91% of the last 1 year)
- Revenue (Jun 2026): ₹2,471 Cr (+27.9% on a year ago)
- Profit (Jun 2026): ₹138 Cr (+94.4% on a year ago)
- Net margin: 5.6% (+1.9 points on a year ago)
- ROE: 3%, FY26

The main question: the share price moved −2.3% in a year while yearly earnings per share moved −39.3%. The difference came from the market paying a higher multiple. ## What is the Niva Bupa Health Insurance Company share price today? Niva Bupa Health Insurance Company Ltd's share price was ₹73.35 at the close on 3 November 2026. It has been falling for 3 weeks. That is 8.0% below its average price over the last 200 trading days. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 14 weeks running. In the last 52 weeks it traded between ₹70 and ₹87, and at that close it sat 20% of the way up from that low. Over the last 2 years the share price moved −1% while the NIFTY 500 moved +0%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 31 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Niva Bupa Health Insurance Company this quarter? Three changes stood out: profit grew again in the June 2026 quarter, revenue up on a year earlier for 8 quarters in a row (every quarter we can compare) and foreign funds (FIIs) raised their stake for 3 quarters in a row. 1. Profit grew again in the June 2026 quarter Profit was ₹138 crore, +94.4% on a year earlier (₹71 crore), after 3 quarters of decline. Why: Profit rose because claims costs improved, helped by avoiding badly priced large group accounts and focusing on smaller groups with better prices. Next results: check if claims costs stay low through the infection season. From the earnings call on 30 Jul 2026. 2. Revenue up on a year earlier for 8 quarters in a row (every quarter we can compare) In the June 2026 quarter revenue was ₹2,471 crore, +27.9% on a year earlier. Why: Revenue rose because new retail health policies grew quickly and renewals made up most of the retail book. Next results: check whether retail health keeps growing 8.0% to 10.0% faster than the market. From the earnings call on 30 Jul 2026. 3. Foreign funds (FIIs) raised their stake for 3 quarters in a row From 10.3% to 13% of the company by the September 2026 quarter. ## What are Niva Bupa Health Insurance Company's latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Niva Bupa Health Insurance Company reported total income of ₹2,471 crore, up 27.9% from ₹1,932 crore a year earlier, and a profit of ₹138 crore, up 94.4% from ₹71.0 crore. ### Niva Bupa Health Insurance Company results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Total income | ₹2,471 crore | ₹1,932 crore | +27.9% |
| Profit | ₹138 crore | ₹71.0 crore | +94.4% |
| Earnings per share | ₹0.75 | ₹0.39 | +92.3% |
| Net margin | 5.6% | 3.7% | +1.9 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Niva Bupa Health Insurance Company's management discussed these results on a call held on 30 July 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Income and profit in ₹ crore.)

## What is the Niva Bupa Health Insurance Company share price history? Niva Bupa Health Insurance Company closed at ₹73.35 on 3 November 2026, down 2.3% from ₹75.06 a year earlier (31 October 2025). Its highest weekly close since November 2024 was ₹95.02 on 6 December 2024. ### Niva Bupa Health Insurance Company share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹71.93 | +2.0% |
| 1 month ago · 1 Oct 2026 | ₹72.98 | +0.5% |
| 6 months ago · 30 Apr 2026 | ₹78.32 | −6.3% |
| 1 year ago · 31 Oct 2025 | ₹75.06 | −2.3% |
| Earliest weekly close in our records · 14 Nov 2024 | ₹74.02 | −0.9% |
| Highest weekly close since November 2024 · 6 Dec 2024 | ₹95.02 | −22.8% |
| Lowest weekly close since November 2024, also the 52-week low · 27 Mar 2026 | ₹69.93 | +4.9% |
| 52-week high (weekly close) · 31 Jul 2026 | ₹87.01 | −15.7% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (110 weekly closes from 14 November 2024 to 3 November 2026.)

## What is the latest news on Niva Bupa Health Insurance Company? 3 Nov 2026: Niva Bupa Health Insurance Company closed at ₹73.35, up 2.0% on the week and up 0.5% on the month. 30 Jul 2026: Niva Bupa Health Insurance Company held its results call for April to June 2026. Management guided: July to September 2026 repeat of the industry health-insurance awareness campaign; oncology and cancer position statements also expected to roll out. ### Earlier

- Results for April to June 2026: Total income up 27.9% and profit up 94.4% on a year earlier. ## What dividend does Niva Bupa Health Insurance Company pay? Niva Bupa Health Insurance Company has paid no dividend on the NSE since its first NSE close in our records (14 November 2024), the start of the period we checked. No. Niva Bupa Health Insurance Company Ltd paid out 0% of its profit as dividends in each of its last 8 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Niva Bupa Health Insurance Company management say on the latest results call? On the call for April to June 2026, held on 30 July 2026, Niva Bupa Health Insurance Company's management guided: July to September 2026 repeat of the industry health-insurance awareness campaign; oncology and cancer position statements also expected to roll out. > “We expect to sustain retail health growth that is 8.0%-10.0% faster than the market”
> Krishnan Ramachandran, on the call for April to June 2026

### What management guided

- Retail health growth 8.0%-10.0% faster than market, supported by continued Bharat expansion, advisor additions and the same level of distribution spending. - Retail/group business mix around 70.0%/30.0%. - High-single-digit annual renewal price increases to support an approximately 75.0% renewal loss ratio. - Expense of management ratio expected to stabilize near 32.0%-33.0%. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijoristack.ai/concall/transcript/58158-30-Jul-2026.pdf). (From the call for April to June 2026, 30 July 2026.)

## What to watch in Niva Bupa Health Insurance Company's next results? When Niva Bupa Health Insurance Company reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Q2 retail health growth versus industry growth, with management aiming for 8.0%-10.0% outperformance and continued advisor and distribution expansion. - What to check (from the call)
- Q2 retail health growth versus industry growth, with management aiming for 8.0%-10.0% outperformance and continued advisor and distribution expansion. - Loss ratio through the infection season; July was in line with plan and management expects no material H1/H2 deterioration. - Expense and reinsurance convergence, including whether GST comparability improves from Q3 and the expense ratio progresses toward 32.0%-33.0%. - Group health renewal trajectory and pricing discipline, including whether SME momentum begins to offset B2B renewal attrition. ## Which stock lists is Niva Bupa Health Insurance Company on? Niva Bupa Health Insurance Company is on 2 of our India lists: Small & mid cap stocks and Penny stocks. - [Small & mid cap stocks Size rank in India: 473](https://www.sectoralpha.in/small-cap-stocks-india)
- [Penny stocks](https://www.sectoralpha.in/penny-stocks-india)

## Is Niva Bupa Health Insurance Company profitable? Niva Bupa Health Insurance Company Ltd earned ₹138 Cr of net profit in the Jun 2026 quarter, +94.4% on the same quarter a year earlier. Full-year FY26 profit was ₹131 Cr. That is 5.6% of the quarter's revenue. The same quarter a year earlier earned ₹71.0 Cr. 4 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was ₹131 Cr (−38.8% on the year before). Why profit moved: revenue changed +27.9% on a year earlier and the margin moved +1.9 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed −268.6% and revenue +27.5%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Niva Bupa Health Insurance Company make, and is it growing? Niva Bupa Health Insurance Company Ltd reported ₹2,471 Cr of income in the Jun 2026 quarter, +27.9% on the same quarter a year earlier. That is the 8th quarter in a row with growth on the year before. Over 7 years it has grown 34.3% a year on average. The last full year, FY26, came in at ₹6,695 Cr. The last four reported quarters add to ₹7,907 Cr. FY26 revenue was ₹6,695 Cr, +24.6% on the year before. Recent pace: the last four quarters grew +27.5% on average, against 34.3% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +27.9%, against +33.5% a year over the last 8 quarters (rolling over); profit over the last 12 months grew −42.6%, against +13.5% a year (rolling over). ## How much does Niva Bupa Health Insurance Company keep from what it earns? Niva Bupa Health Insurance Company Ltd's net margin was 5.6% in the Jun 2026 quarter, 1.9 percentage points higher than the same quarter a year ago. Across 8 years it has been between −10.5% and 4.0%. The latest quarter is above every full year in that period. Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## How many of Niva Bupa Health Insurance Company's loans have gone bad? Niva Bupa Health Insurance Company Ltd does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report. Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up. ## How fast is Niva Bupa Health Insurance Company's loan book growing? Niva Bupa Health Insurance Company Ltd's revenue was ₹6,695 Cr in FY26, +24.6% on the year before, so the loan book is growing. The latest quarter was +27.9% on a year earlier. The net margin on that income is 5.6%, +1.9 percentage points on a year ago. Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year. In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Gross NPA is the loan-quality figure this page uses. ## What is Niva Bupa Health Insurance Company's P/BV ratio, and how does it compare with its own history? Niva Bupa Health Insurance Company Ltd's P/BV is 3.6×, near the low end of its own history: it has been lower only 9% of the time. Its usual P/BV (the middle reading) is 4.0×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is low: this lender earns about 3% a year on its equity. A lender that earns less on its net worth is valued lower for each rupee of it, and that gap usually closes only if returns improve. Why the multiple is where it is: over the past year book value grew while the price moved −2.3%. Price and book value moved together, so the multiple stayed in its range. In short: the multiple is low against its own past, so the book value trend underneath matters more than the multiple. The PEG ratio and its quarterly curve, which only the second data source has, are not shown on this page: its two data sources disagree by up to 860% on reported income across 12 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Is the Niva Bupa Health Insurance Company business getting better or worse? Niva Bupa Health Insurance Company Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 8 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Niva Bupa Health Insurance Company earn on its equity and assets? We do not have a clean yearly return-on-equity history for Niva Bupa Health Insurance Company Ltd. For an insurer in particular, the usual bank ratios do not fit, so this page does not force them or estimate a series. The revenue, margin and ownership sections show what this company does report. The quarterly return-on-equity and return-on-assets curves, which only the second data source has, are not shown on this page: its two data sources disagree by up to 860% on reported income across 12 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data. ## Does Niva Bupa Health Insurance Company have too much debt? For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead. For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here. ## What is the Niva Bupa Health Insurance Company shareholding pattern? Domestic institutions raised their stake in Niva Bupa Health Insurance Company Ltd by 6.1 percentage points over 7 quarters, the biggest change among its owners. Domestic institutions now own 15.9% of the company. Foreign institutions moved +4.1 points over the same period, to 12.9%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: +6.1 points over 7 quarters, to 15.9%; Foreign institutions: +4.1 points over 7 quarters, to 12.9%; Promoters: −0.7 points over 7 quarters, to 55.3%. Why the owners changed: domestic institutions drove it (+6.1 points), together with foreign institutions (+4.1 points). They raised their stake step by step. ## How far is Niva Bupa Health Insurance Company from balance-sheet trouble? For Niva Bupa Health Insurance Company Ltd, the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead. ## How does Niva Bupa Health Insurance Company rank in its industry? 42.3 out of 100, rank 5 of 8 in Finance - Insurance, with 58% of the evidence available. Niva Bupa Health Insurance Company Ltd scores 42.3 out of 100 against the 8 companies it is compared with in Finance - Insurance, ranking 5. Some evidence is missing, so the score is pulled toward the middle on purpose. The four parts add up to the total exactly: 17.1 + 8.9 + 3.8 + 12.5 = 42.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector. ## Which companies is Niva Bupa Health Insurance Company compared with? Niva Bupa Health Insurance Company ranks 5 of 8 Finance - Insurance companies on the 4-Factor Sector Score, with 42.3 out of 100. 1. [Life Insurance Corporation of India](https://www.sectoralpha.in/stocks/life-insurance-corporation-of-india) LICI · basing · Most evidence points up · 73% evidence 72.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.6/35 · Income 10.1% · Profit 23.3% · 45% evidence Capital efficiency 17.3/25 · ROA 0.7% · ROE 37.8% · GNPA n/a · 68% evidence Valuation 19.7/20 · P/BV 2.74× · P/BV÷ROE 0.07 · 100% evidence Relative strength 16.0/20 · Lead over its industry 5% · Lead over NIFTY 500 -3% · 1 year -14.3% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.6 + 17.3 + 19.7 + 16 = 72.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [ICICI Prudential Life Insurance Company Ltd](https://www.sectoralpha.in/stocks/icici-prudential-life-insurance-company-ltd) ICICIPRULI · Evidence leans up · 68% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 29.9/43.75 · Income 15.8% · Profit 34% · 86% evidence Capital efficiency 12.4/31.25 · ROA 0.4% · ROE 10% · GNPA n/a · 72% evidence Valuation 13.2/25 · P/BV 4.41× · P/BV÷ROE 0.44 · 100% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 29.9 + 12.4 + 13.2 = 55.5 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 3. [Go Digit General Insurance Ltd](https://www.sectoralpha.in/stocks/go-digit-general-insurance-ltd) GODIGIT · turning · Evidence leans up · 78% evidence 50.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.8/35 · Income 7.3% · Profit 6.5% · 75% evidence Capital efficiency 18.1/25 · ROA 2.2% · ROE 12.2% · GNPA n/a · 72% evidence Valuation 8.0/20 · P/BV 5.18× · P/BV÷ROE 0.42 · 70% evidence Relative strength 8.0/20 · Lead over its industry -3.4% · Lead over NIFTY 500 -11% · 1 year -27.3% · 100% evidence · 2 of 12 weeks ahead Exact sum: 16.8 + 18.1 + 8 + 8 = 50.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [SBI Life Insurance Company Ltd](https://www.sectoralpha.in/stocks/sbi-life-insurance-company-ltd) SBILIFE · quiet · Evidence leans down · 67% evidence 45.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.4/35 · Income 16.4% · Profit 8.2% · 86% evidence Capital efficiency 12.7/25 · ROA 0.4% · ROE 13.7% · GNPA n/a · 72% evidence Valuation 5.1/20 · P/BV 8.09× · P/BV÷ROE 0.59 · 70% evidence Relative strength 9.1/20 · Lead over its industry n/a · Lead over NIFTY 500 -7.2% · 1 year -15.2% · 25% evidence · 1 of 12 weeks ahead Exact sum: 18.4 + 12.7 + 5.1 + 9.1 = 45.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. Niva Bupa Health Insurance Company Ltd this page NIVABUPA · quiet · Too little evidence to rank firmly · 58% evidence 42.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.1/35 · Income 27.9% · Profit -42.6% · 45% evidence Capital efficiency 8.9/25 · ROA n/a · ROE 3.5% · GNPA n/a · 34% evidence Valuation 3.8/20 · P/BV 3.54× · P/BV÷ROE 1.02 · 70% evidence Relative strength 12.5/20 · Lead over its industry 4.9% · Lead over NIFTY 500 -3% · 1 year -3.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 17.1 + 8.9 + 3.8 + 12.5 = 42.3 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 6. [HDFC Life Insurance Company Ltd](https://www.sectoralpha.in/stocks/hdfc-life-insurance-company-ltd) HDFCLIFE · breaking out · Evidence leans down · 67% evidence 40.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.2/35 · Income 17.4% · Profit 8.3% · 86% evidence Capital efficiency 10.8/25 · ROA 0.4% · ROE 11.3% · GNPA n/a · 72% evidence Valuation 6.3/20 · P/BV 5.86× · P/BV÷ROE 0.52 · 70% evidence Relative strength 7.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -12.3% · 1 year -28.3% · 25% evidence · 0 of 12 weeks ahead Exact sum: 16.2 + 10.8 + 6.3 + 7.5 = 40.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Religare Enterprises Ltd](https://www.sectoralpha.in/stocks/religare-enterprises-ltd) RELIGARE · quiet · Too little evidence to rank firmly · 52% evidence 38.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.0/35 · Income 19% · Profit -80% · 45% evidence Capital efficiency 8.1/25 · ROA 0.4% · ROE 3.2% · GNPA n/a · 68% evidence Valuation 5.2/20 · P/BV 2.43× · P/BV÷ROE 0.76 · 70% evidence Relative strength 9.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -5.8% · 1 year -19.5% · 25% evidence · 2 of 12 weeks ahead Exact sum: 15 + 8.1 + 5.2 + 9.7 = 38 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 8. [Canara HSBC Life Insurance Company Ltd](https://www.sectoralpha.in/stocks/canara-hsbc-life-insurance-company-ltd) CANHLIFE · losing its lead · Evidence leans down · 76% evidence 35.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.0/35 · Income 21.4% · Profit 7.2% · 86% evidence Capital efficiency 5.8/25 · ROA 0.2% · ROE 8.1% · GNPA n/a · 72% evidence Valuation 4.0/20 · P/BV 7.03× · P/BV÷ROE 0.87 · 70% evidence Relative strength 6.3/20 · Lead over its industry -2.6% · Lead over NIFTY 500 -10% · 1 year 4.3% · 70% evidence · 8 of 12 weeks ahead Exact sum: 19 + 5.8 + 4 + 6.3 = 35.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Finance - Insurance](https://www.sectoralpha.in/sectors/finance-insurance), all 8 compared on one page. ## Which companies are close to Niva Bupa Health Insurance Company in size? Niva Bupa Health Insurance Company is the 6th largest of 8 Finance - Insurance companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: SBI Life Insurance Company, HDFC Life Insurance Company, ICICI Prudential Life Insurance Company and Go Digit General Insurance. Just below it: Canara HSBC Life Insurance Company and Religare Enterprises. ### Finance - Insurance companies close in size

1. [SBI Life Insurance Company Ltd](https://www.sectoralpha.in/stocks/sbi-life-insurance-company-ltd) ₹1,66,425 crore
2. [HDFC Life Insurance Company Ltd](https://www.sectoralpha.in/stocks/hdfc-life-insurance-company-ltd) ₹1,14,039 crore
3. [ICICI Prudential Life Insurance Company Ltd](https://www.sectoralpha.in/stocks/icici-prudential-life-insurance-company-ltd) ₹64,580 crore
4. [Go Digit General Insurance Ltd](https://www.sectoralpha.in/stocks/go-digit-general-insurance-ltd) ₹24,109 crore
5. Niva Bupa Health Insurance Company Ltd ₹13,435 crore
6. [Canara HSBC Life Insurance Company Ltd](https://www.sectoralpha.in/stocks/canara-hsbc-life-insurance-company-ltd) ₹11,534 crore
7. [Religare Enterprises Ltd](https://www.sectoralpha.in/stocks/religare-enterprises-ltd) ₹7,321 crore

[All 8 Finance - Insurance companies, largest first](https://www.sectoralpha.in/sectors/finance-insurance#all-companies)

### Companies close in size in other industries

1. [Gallantt Ispat Ltd.](https://www.sectoralpha.in/stocks/gallantt-ispat-ltd) ₹13,465 crore · Steel Products
2. [JSW Dulux Ltd](https://www.sectoralpha.in/stocks/jsw-dulux-ltd) ₹13,436 crore · Building Materials - Paints
3. Niva Bupa Health Insurance Company Ltd ₹13,435 crore
4. [Paradeep Phosphates Ltd](https://www.sectoralpha.in/stocks/paradeep-phosphates-ltd) ₹13,407 crore · Fertilisers
5. [CIE Automotive India Ltd](https://www.sectoralpha.in/stocks/cie-automotive-india-ltd) ₹13,384 crore · Castings, Forgings & Fastners

## What else do people ask about Niva Bupa Health Insurance Company? ### What is Niva Bupa Health Insurance Company's share price today? Niva Bupa Health Insurance Company Ltd's share price is ₹73.35, −2.3% over the past year. The whole company is worth ₹13,574 Cr on the market. In the last 52 weeks it traded between ₹70 to ₹87; today it is 20% of the way up from the low, 8.0% below its 200-day average (as of 3 November 2026). ### What were Niva Bupa Health Insurance Company's latest quarterly results? Niva Bupa Health Insurance Company Ltd reported total income of ₹2,471 Cr and net profit of ₹138 Cr for the Jun 2026 quarter. Income rose 27.9% and profit rose 94.4% compared with a year earlier. Earnings per share were ₹0.75 (as of 3 November 2026). ### What is Niva Bupa Health Insurance Company's market cap? Niva Bupa Health Insurance Company Ltd's market capitalisation is ₹13,574 Cr at a share price of ₹73.35. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Niva Bupa Health Insurance Company performing? Niva Bupa Health Insurance Company Ltd's share price has been falling for 3 weeks. In its latest quarter, income rose 27.9% and profit rose 94.4% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 14 weeks running (as of 3 November 2026). ### Will Niva Bupa Health Insurance Company's share price go up? This page does not forecast Niva Bupa Health Insurance Company Ltd's share price. What it shows instead: the share price is ₹73.35, and it has been falling for 3 weeks. Its P/BV of 3.6× is higher than 9% of its own last 2 years (as of 3 November 2026). ### Where is Niva Bupa Health Insurance Company in its business cycle? Niva Bupa Health Insurance Company Ltd's FY26 net margin was 2.0%, against a 8-year range of −10.5% to 4.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 5.6%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Niva Bupa Health Insurance Company story? The main question: the share price moved −2.3% in a year while yearly earnings per share moved −39.3%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Niva Bupa Health Insurance Company a stock worth studying right now? What the numbers show: Niva Bupa Health Insurance Company Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Niva Bupa Health Insurance Company share price forecast for 2026? What management itself guided: July to September 2026 repeat of the industry health-insurance awareness campaign; oncology and cancer position statements also expected to roll out. ## Lists

- Small & mid cap stocks: https://www.sectoralpha.in/small-cap-stocks-india
- Penny stocks: https://www.sectoralpha.in/penny-stocks-india

This is research, not advice. We’re not SEBI-registered.